#bronchiectasis — Friday, October 09, 2026 (1 items)
| 5 | ℹ |
Translational and phase I evaluation of AZD0292, a novel, half-life extended anti-Pseudomonal Psl-PcrV bispecific monoclonal antibody.
(academic.oup.com)
|
Journal of Infectious Diseases 2026-10-09 | #antibody #immunotherapy #bronchiectasis #infection #pseudomonas |